Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer.

Camps, Carlos; Sirera, Rafael; Bremnes, Roy M; Ródenas, Vanessa; Blasco, Ana; Safont, María José; Garde, Javier; Juarez, Asuncion; Caballero, Cristina; Sanchez, Josie Javier; Taron, Miquel; Rosell, Rafael

Camps, Carlos; Sirera, Rafael; Bremnes, Roy M; Ródenas, Vanessa; Blasco, Ana; Safont, María José; Garde, Javier; Juarez, Asuncion; Caballero, Cristina; Sanchez, Josie Javier; Taron, Miquel; Rosell, Rafael.

Affiliation

Camps C; Servicio de Oncología Médica, Fundación Investigación, Hospital General Universitario, Valencia, Spain. camps_car@gva.es

Anticancer Res ; 26(6C): 4905-9, 2006.

Article in En | MEDLINE | ID: mdl-17214360

Subject(s)

Carcinoma, Non-Small-Cell Lung/enzymology; DNA, Neoplasm/blood; Lung Neoplasms/enzymology; Telomerase/genetics; Adult; Aged; Carcinoma, Non-Small-Cell Lung/genetics; Carcinoma, Non-Small-Cell Lung/pathology; Catalytic Domain; Female; Humans; Lung Neoplasms/genetics; Lung Neoplasms/pathology; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Survival Rate; Telomerase/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Carcinoma, Non-Small-Cell Lung / Telomerase / Lung Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Anticancer Res Year: 2006 Document type: Article Affiliation country: Spain Country of publication: Greece

Search on Google

Add to My VHL

XML

PubMed Links